Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy. [electronic resource]
Publication details: Journal of market access & health policy 2017Description: 1393308 p. digitalISSN:- 2001-6689
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.